Información del producto
- (3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-10-hydroxyimino-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
- (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione 10-oxime (non-preferred name)
- 9-Hydroxyiminoerythromycin
- Erythromycin 9-ketoxime
- Erythromycin A 9-oxime
- Erythromycin, 9-oxime
- Oxacyclotetradecane, erythromycin deriv.
- Ru 28111
- Unii-10W452Cmtz
Impurity Clarithromycin EP Impurity J
Applications Erythromycin A Oxime (Roxithromycin Impurity C) (Clarithromycin EP Impurity J) is the major metabolite of Roxithromycin and an intermediate of Azithromycin. Antibacterial agent. Roxithromycin impurity C.
References Ferrero, J., et al.: Drug Metab. Dispos., 18, 441 (1990), Gase, C., et al.: J. Antibiot., 44, 313 (1991), Markham, A., et al.: Drugs, 48, 297 (1994), Jarukamjorn, K., et al.: J. Pharm. Pharmacol., 50, 515 (1998),
Propiedades químicas
Consulta técnica sobre: TR-E650010 Erythromycin A Oxime
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.